We brought Axe Trade Capital onto a single screen — licensing, ownership, and the withdrawal trail — and read what the evidence showed. The picture that emerged is one of elevated risk: Axe Trade Capital…
Cryptohud reviewed KucoinRX against the patterns we see most often in investment-fraud cases. The picture that emerged is one of elevated risk: KucoinRX has drawn cautions from regulators who have flagged operations associated with it.…
Our analysts put CFD Capitals on the Cryptohud control room and worked the signals in order. The picture that emerged is one of elevated risk: CFD Capitals operates without verifiable authorisation from any recognised financial…
Our analysts put Elite Wealth Consultants on the Cryptohud control room and worked the signals in order. The picture that emerged is one of elevated risk: Elite Wealth Consultants has drawn cautions from regulators who…
When Atcfx crossed our desk, we ran it through the same heads-up assessment we apply to every platform. The picture that emerged is one of elevated risk: Atcfx operates without verifiable authorisation from any recognised…
We brought MSquare onto a single screen — licensing, ownership, and the withdrawal trail — and read what the evidence showed. The picture that emerged is one of elevated risk: MSquare operates without verifiable authorisation…
We brought BluVox onto a single screen — licensing, ownership, and the withdrawal trail — and read what the evidence showed. The picture that emerged is one of elevated risk: BluVox operates without verifiable authorisation…
Cryptohud reviewed EvincoInvest against the patterns we see most often in investment-fraud cases. The picture that emerged is one of elevated risk: EvincoInvest has drawn cautions from regulators who have flagged operations associated with it.…
When Invidiatrade crossed our desk, we ran it through the same heads-up assessment we apply to every platform. The picture that emerged is one of elevated risk: Invidiatrade leans on a registration that does not…
We brought Levrix onto a single screen — licensing, ownership, and the withdrawal trail — and read what the evidence showed. The picture that emerged is one of elevated risk: Levrix shows the hallmarks of…